← All organizations

King Khaled Eye Specialist Hospital

Academic/HospitalWebsite ↗

Also known as: Fowzan Alkuraya | J. Fernando Arevalo, MD FACS | King Khaled University Hospital

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

Apr 12, 2020

Timeline

1970s

Jan 1, 1979
King Khaled Eye Specialist Hospital— Founded

Drugs by trial phase (11 distinct, 7 trials)

Phase 4 (1 own, 0 via acquisition)

bevacizumab

Phase 3 (3 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

COVID-19 convalescent plasma

Phase 1 (1 own, 0 via acquisition)

adeno-associated virus

Other trials (5 own, 0 via acquisition)

Indications

Studied for

Recent trials (14)

NCT04347681CollaboratorPhase 2Apr 12, 2020
NCT01976923Lead sponsorPhase 3Nov 1, 2013
NCT01976923Sponsor investigatorPhase 3Nov 1, 2013
NCT01829295CollaboratorPhase 3Aug 1, 2013
NCT02096874Lead sponsorPhase 4Jun 1, 2013
NCT02096874Overall official - principal investigatorPhase 4Jun 1, 2013
NCT02096874Reponsible party - principal investigatorPhase 4Jun 1, 2013
NCT01482195Sponsor investigatorPhase 1Aug 1, 2011
NCT01482195CollaboratorPhase 1Aug 1, 2011
NCT01482195Lead sponsorPhase 1Aug 1, 2011
NCT00918190Overall official - principal investigatorN/AJun 1, 2009
NCT00918190Lead sponsorN/AJun 1, 2009
NCT00238862Overall official - principal investigatorN/AOct 1, 2005
NCT00238862Lead sponsorN/AOct 1, 2005

Details

Founded: Riyadh, SA Jan 1, 1979
Last known activity: Apr 12, 2020